XML 36 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Equity Plans
3 Months Ended
Nov. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Equity Plans
Equity Plans

As of November 30, 2017, 99 million shares of our common stock were available for future awards under our equity plans.

Stock Options

Quarter ended
 
November 30,
2017
 
December 1,
2016
Stock options granted
 
1

 
2

Weighted-average grant-date fair value per share
 
$
17.67

 
$
7.66

Average expected life in years
 
5.6

 
5.7

Weighted-average expected volatility
 
44
%
 
46
%
Weighted-average risk-free interest rate
 
2.1
%
 
1.4
%
Expected dividend yield
 
0.0
%
 
0.0
%

Restricted Stock and Restricted Stock Units ("Restricted Stock Awards")

Quarter ended
 
November 30,
2017
 
December 1,
2016
Restricted stock award shares granted
 
2

 
3

Weighted-average grant-date fair value per share
 
$
39.01

 
$
18.22



Stock-based Compensation Expense

Quarter ended
 
November 30,
2017
 
December 1,
2016
Stock-based compensation expense by caption
 
 
 
 
Cost of goods sold
 
$
20

 
$
19

Selling, general, and administrative
 
18

 
15

Research and development
 
13

 
12

 
 
$
51

 
$
46

 
 
 
 
 
Stock-based compensation expense by type of award
 
 
 
 
Stock options
 
$
17

 
$
17

Restricted stock awards
 
34

 
29

 
 
$
51

 
$
46



As of November 30, 2017, $348 million of total unrecognized compensation costs for unvested awards was expected to be recognized through the first quarter of 2022, resulting in a weighted-average period of 1.2 years.